Valuation
- Market cap
- 44,291,000
- Revenue TTM
- $78,490,000
- Net income TTM
- $-10,370,000
- P/E (trailing)
- 0.00
- P/E (forward)
- —
- Profit margin
- -13.21%
- Debt to equity
- 0.18
Trading
- Volume
- 2,400
- Avg volume
- 16,124
- Day's range
- $3.99 – $4.11
- Shares out
- 10,936,000
- Stochastic %K
- 8%
- Beta
- 1.51
- Analysts
- —
- Price target
- $7.00
Company profile
InterCure Ltd., together with its subsidiaries, engages in the production, manufacturing, and distribution of pharmaceutical-grade cannabis and cannabis-based products for medical use in Israel and internationally. The company offers dried cannabis inflorescences and cannabis extract mixed with oil. It also invests in the biomed sector. The company was incorporated in 1994 and is headquartered in Herzliya, Israel.
- Industry
- Drug Manufacturers - Specialty & Generic
- Sector
- Healthcare
- Phone
- 972 7 746 05012
- Website
- https://www.intercure.co
- Address
- 85 Medinat ha-Yehudim Street, Herzliya, Israel
Latest news
No headlines yet.
